DKK3 and neoplasm: At the end of treatment, on day 14 after the start of treatment, tumour volumes showed significant decrease in the Bxpc‐3‐DKK3 group compared with Bxpc‐3‐NC and Bxpc‐3 (P < 0.05; Fig. 6A).